Clinical Trial Update: Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing Paclitaxel followed by FEC versus Paclitaxel with RAD001 (everolimus) followed by FEC in women with breast cancer; results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Epirubicin (epirubicin)
• Everolimus (everolimus)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN | Results posted: 2013-10-31